Gene · 1948
Papers2,853
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,853
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Disintegrin and Metalloproteinase 10 Regulates Ephrin B2-Mediated Endothelial Cell Sprouting and Ischemic Retinopathy. | Am J Pathol | 2025 | 40252970 | PubTator, text mining | PubMed |
| Bloodhounds chasing the origin of blood cells. | Trends Cell Biol | 2025 | 40221343 | PubTator, text mining | PubMed |
| Cathepsin S: A key drug target and signalling hub in immune system diseases. | Int Immunopharmacol | 2025 | 40220622 | PubTator, text mining | PubMed |
| Kaempferol combats the osteogenic differentiation damage of periodontal ligament stem cells in periodontitis via regulating EphrinB2-mediated PI3K/Akt and P38 pathways. | Phytomedicine | 2025 | 40220409 | PubTator, text mining | PubMed |
| Changes in vascular identity during vascular remodeling. | JVS Vasc Sci | 2025 | 40213096 | PubTator, text mining | PubMed |
| The paradigm shifts of periodontal regeneration strategy: From reparative manipulation to developmental engineering. | Bioact Mater | 2025 | 40165829 | PubTator, text mining | PubMed |
| Hyperalgesic Priming in the Transition From Acute to Chronic Pain: Focus on Different Models and the Molecular Mechanisms Involved. | J Pain Res | 2025 | 40135188 | PubTator, text mining | PubMed |
| Alendronate inhibits bone-specific blood vessels in the femoral metaphyses of mice. | J Oral Biosci | 2025 | 40118179 | PubTator, text mining | PubMed |
| Exploring the causal relationship between serum EFNB2 levels and epilepsy: a bidirectional Mendelian randomization and co-localization analysis. | BMC Neurol | 2025 | 40045230 | PubTator, text mining | PubMed |
| Melatonin enhances neurogenesis and neuroplasticity in long-term recovery following cerebral ischemia in mice. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39993544 | PubTator, text mining | PubMed |
| Multifaceted analysis of noncoding and coding de novo variants implicates NOTCH signaling pathway in tetralogy of Fallot in Chinese population. | HGG Adv | 2025 | 39921258 | PubTator, text mining | PubMed |
| Ephrin-B2 acts as a positive regulator of osteogenesis-angiogenesis coupling. | Int J Biol Macromol | 2025 | 39894124 | PubTator, text mining | PubMed |
| Inhibition of EphB4 Receptor Signaling by Ephrin-B2-Competitive and Non-Competitive DARPins Prevents Angiogenesis. | Biochemistry | 2025 | 39818753 | PubTator, text mining | PubMed |
| Understanding and addressing the global impact: A systematic review and cross-sectional bibliometric analysis of Langya henipavirus and pre-existing severe henipaviruses. | J Infect Public Health | 2025 | 39778464 | PubTator, text mining | PubMed |
| Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes. | Am J Clin Pathol | 2025 | 39705501 | PubTator, text mining | PubMed |
| EphA4 Mediates EphrinB1-Dependent Adhesion in Retinal Ganglion Cells. | J Neurosci | 2025 | 39622649 | PubTator, text mining | PubMed |
| Germline alteration analysis reveals EPHB4R91H mutation as a key player in multiple primary lung tumors. | Carcinogenesis | 2025 | 39574310 | PubTator, text mining | PubMed |
| Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC. | Oncogene | 2025 | 39489818 | PubTator, text mining | PubMed |
| Dihydroartemisinin Modulates Prostate Cancer Progression by Regulating Multiple Genes via the Transcription Factor NR2F2. | Curr Pharm Biotechnol | 2025 | 39364872 | PubTator, text mining | PubMed |
| Proteomics of left ventricular structure in the Multi-Ethnic Study of Atherosclerosis. | ESC Heart Fail | 2025 | 39263947 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1948/papers?page=6